Home > EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl).

European Monitoring Centre for Drugs and Drug Addiction. (2017) EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl). Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl)) - Published Version
1MB

In September 2016, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, commonly known as acryloylfentanyl, through a joint assessment based upon the following criteria:

1. the amount of the material seized;

2. evidence of organised crime involvement;

3. evidence of international trafficking;

4. analogy with better-studied compounds;

5. evidence of the potential for further (rapid) spread; and,

6. evidence of cases of serious intoxication or fatalities.

The EMCDDA and Europol agreed that the information collected on acryloylfentanyl satisfied criteria 4 and 6. The two agencies therefore concluded that sufficient information had been accumulated to merit the production of a Joint Report on acryloylfentanyl as stipulated by Article 5.1 of the Council Decision.

Date:February 2017
Pages:24 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > New (novel) psychoactive substances
E Concepts in biomedical areas > Substance by legal status
MM-MO Crime and law > Substance related offence > Drug offence > Illegal drug possession (seizures)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland

Repository Staff Only: item control page